Canvog M 1mg/500mg/0.2mg Tablet SR
Marketer
Canipla Care
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Canvog M 1mg/500mg/0.2mg Tablet SR
Diabex Trio 1mg/500mg/0.2mg Extended-Release Tablets are categorized as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. Diabex Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, and tremors—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources, such as sugary snacks or juice, are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.
Primary Ingredients of Canvog M 1mg/500mg/0.2mg Tablet SR
No text provided to rephrase.
Uses of Canvog M 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Canvog M 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Canvog M 1mg/500mg/0.2mg Sustained-Release Tablets on an empty stomach.
Common Side effects of Canvog M 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Canvog M 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Canvog M 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Canvog M 1mg/500mg/0.2mg Tablet SR works:
Canvog M extended-release tablets (1 mg/500 mg/0.2 mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Canvog M 1mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Canvog M 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Canvog M 1mg/500mg/0.2mg SR tablets is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Canvog M 1mg/500mg/0.2mg Tablet SR is likely unsafe for individuals with impaired kidney function and should be omitted. Medical advice is necessary. Furthermore, its administration is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Canvog M 1mg/500mg/0.2mg SR tablets. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Canvog M 1mg/500mg/0.2mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Canvog M 1mg/500mg/0.2mg Tablet SR :
Should you forget a Canvog M 1mg/500mg/0.2mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Canvog M 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently